Protein name:
Oncostatin-M-specific receptor subunit beta ;
Alternative:
Interleukin-31 receptor subunit beta (IL-31 receptor subunit beta;IL-31R subunit beta;IL-31R-beta;IL-31RB) ;
Organism:
Human (Homo sapiens).
General Annotation
Sub Unit:
Heterodimer composed of OSMR and IL6ST (type II OSM receptor). Heterodimer with IL31RA to form the IL31 receptor.
Function:
Associates with IL31RA to form the IL31 receptor. Binds IL31 to activate STAT3 and possibly STAT1 and STAT5. Capable of transducing OSM-specific signaling events.
Subcellular Location:
Membrane
Single-pass type I membrane protein
Protein Attributes:
50:
MALFAVFQTT | FFLTLLSLRT | YQSEVLAERL | PLTPVSLKVS | TNSTRQSLHL |
100:
QWTVHNLPYH | QELKMVFQIQ | ISRIETSNVI | WVGNYSTTVK | WNQVLHWSWE |
150:
SELPLECATH | FVRIKSLVDD | AKFPEPNFWS | NWSSWEEVSV | QDSTGQDILF |
200:
VFPKDKLVEE | GTNVTICYVS | RNIQNNVSCY | LEGKQIHGEQ | LDPHVTAFNL |
250:
NSVPFIRNKG | TNIYCEASQG | NVSEGMKGIV | LFVSKVLEEP | KDFSCETEDF |
300:
KTLHCTWDPG | TDTALGWSKQ | PSQSYTLFES | FSGEKKLCTH | KNWCNWQITQ |
350:
DSQETYNFTL | IAENYLRKRS | VNILFNLTHR | VYLMNPFSVN | FENVNATNAI |
400:
MTWKVHSIRN | NFTYLCQIEL | HGEGKMMQYN | VSIKVNGEYF | LSELEPATEY |
450:
MARVRCADAS | HFWKWSEWSG | QNFTTLEAAP | SEAPDVWRIV | SLEPGNHTVT |
500:
LFWKPLSKLH | ANGKILFYNV | VVENLDKPSS | SELHSIPAPA | NSTKLILDRC |
550:
SYQICVIANN | SVGASPASVI | VISADPENKE | VEEERIAGTE | GGFSLSWKPQ |
600:
PGDVIGYVVD | WCDHTQDVLG | DFQWKNVGPN | TTSTVISTDA | FRPGVRYDFR |
650:
IYGLSTKRIA | CLLEKKTGYS | QELAPSDNPH | VLVDTLTSHS | FTLSWKDYST |
700:
ESQPGFIQGY | HVYLKSKARQ | CHPRFEKAVL | SDGSECCKYK | IDNPEEKALI |
750:
VDNLKPESFY | EFFITPFTSA | GEGPSATFTK | VTTPDEHSSM | LIHILLPMVF |
800:
CVLLIMVMCY | LKSQWIKETC | YPDIPDPYKS | SILSLIKFKE | NPHLIIMNVS |
850:
DCIPDAIEVV | SKPEGTKIQF | LGTRKSLTET | ELTKPNYLYL | LPTEKNHSGP |
900:
GPCICFENLT | YNQAASDSGS | CGHVPVSPKA | PSMLGLMTSP | ENVLKALEKN |
950:
YMNSLGEIPA | GETSLNYVSQ | LASPMFGDKD | SLPTNPVEAP | HCSEYKMQMA |
979:
VSLRLALPPP | TENSSLSSIT | LLDPGEHYC
Vaild Sequence:
Related Databases
Uniprot:
ELISA Kit
CLIA Kit
Polyclonal Antibody
Monoclonal Antibody
Protein
FOR
Human
Rat
Mouse
ELISA Kit for Human Oncostatin-M-specific receptor subunit beta
ELISA Kit for Human Oncostatin-M-specific receptor subunit beta
ELISA Kit for Human Oncostatin-M-specific receptor subunit beta
CLIA Kit for Human Oncostatin-M-specific receptor subunit beta
CLIA Kit for Human Oncostatin-M-specific receptor subunit beta
CLIA Kit for Human Oncostatin-M-specific receptor subunit beta
Polyclonal Antibody for Human Oncostatin-M-specific receptor subunit beta
Polyclonal Antibody for Human Oncostatin-M-specific receptor subunit beta
Polyclonal Antibody for Human Oncostatin-M-specific receptor subunit beta
Monoclonal Antibody for Human Oncostatin-M-specific receptor subunit beta
Monoclonal Antibody for Human Oncostatin-M-specific receptor subunit beta
Monoclonal Antibody for Human Oncostatin-M-specific receptor subunit beta
Protein for Human Oncostatin-M-specific receptor subunit beta
Protein for Human Oncostatin-M-specific receptor subunit beta
Protein for Human Oncostatin-M-specific receptor subunit beta
R&D Technical Data
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Precision
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Recovery
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Linearity
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
References
1.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1);FUNCTION;SUBUNIT;INDUCTION;TISSUE SPECIFICITY
2.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2);VARIANT TRP-210
tissue :
Colon .
tissue :
Placenta .
3.
"Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice."
Dillon S.R.
,
Sprecher C.
,
Hammond A.
,
Bilsborough J.
,
Rosenfeld-Franklin M.
,
Presnell S.R.
,
Haugen H.S.
,
Maurer M.
,
Harder B.
,
Johnston J.
,
Bort S.
,
Mudri S.
,
Kuijper J.L.
,
Bukowski T.
,
Shea P.
,
Dong D.L.
,
Dasovich M.
,
Grant F.J.
,
Lockwood L.
,
Levin S.D.
,
LeCiel C.
,
Waggie K.
,
Day H.
,
Topouzis S.
,
Kramer J.
,
Kuestner R.
,
Chen Z.
,
Foster D.
,
Parrish-Novak J.
,
Gross J.A.
more...
Nat. Immunol.5:752-760(2004)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : FUNCTION;OLIGOMERIZATION;INDUCTION
4.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-826 AND SER-889;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
tissue :
Cervix carcinoma .
5.
"Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."
Olsen J.V.
,
Vermeulen M.
,
Santamaria A.
,
Kumar C.
,
Miller M.L.
,
Jensen L.J.
,
Gnad F.
,
Cox J.
,
Jensen T.S.
,
Nigg E.A.
,
Brunak S.
,
Mann M.
Sci. Signal.3:RA3-RA3(2010)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
tissue :
Cervix carcinoma .
6.
"Oncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosis."
Arita K.
,
South A.P.
,
Hans-Filho G.
,
Sakuma T.H.
,
Lai-Cheong J.
,
Clements S.
,
Odashiro M.
,
Odashiro D.N.
,
Hans-Neto G.
,
Hans N.R.
,
Holder M.V.
,
Bhogal B.S.
,
Hartshorne S.T.
,
Akiyama M.
,
Shimizu H.
,
McGrath J.A.
Am. J. Hum. Genet.82:73-80(2008)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS PLCA1 ALA-618 AND THR-691
7.
"Novel IL31RA gene mutation and ancestral OSMR mutant allele in familial primary cutaneous amyloidosis."
Lin M.W.
,
Lee D.D.
,
Liu T.T.
,
Lin Y.F.
,
Chen S.Y.
,
Huang C.C.
,
Weng H.Y.
,
Liu Y.F.
,
Tanaka A.
,
Arita K.
,
Lai-Cheong J.
,
Palisson F.
,
Chang Y.T.
,
Wong C.K.
,
Matsuura I.
,
McGrath J.A.
,
Tsai S.F.
Eur. J. Hum. Genet.18:26-32(2010)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS PLCA1 VAL-647; LEU-694 AND THR-697